Home 禄 Business 禄 Manufacturing
Deal seals drug JV in Hangzhou
By Ding Yining |
January 30, 2010, Saturday
|
Print Edition
Print Edition
SANOFI-AVENTIS yesterday signed an agreement to set up a joint venture in Zhejiang Province to expand its presence in China's consumer health market.
The new joint venture with Minsheng Pharmaceutical Co will enable the French drug maker to build a manufacturing plant in Hangzhou, capital of Zhejiang Province.
Sanofi-aventis will take the majority stake in the new joint venture, according to a statement by the company yesterday.
The firms, however, didn't reveal the investment amount in the joint venture.
"The new joint venture is a strategic move for us to consolidate our position in the consumer health care sector in world's second-largest over-the-counter market," said Hanspeter Spek, president for global operations at Sanofi-aventis.
For Minsheng Pharmaceutical, the new venture "will serve as a platform to develop more health products as well as expand the reach of our existing products," said Zhu Fujiang, its chairman.
The new venture will focus on manufacturing vitamins and mineral supplements as Minsheng Pharmaceutical is the patent holder of 21 Super-Vita, a multivitamin brand.
The new joint venture with Minsheng Pharmaceutical Co will enable the French drug maker to build a manufacturing plant in Hangzhou, capital of Zhejiang Province.
Sanofi-aventis will take the majority stake in the new joint venture, according to a statement by the company yesterday.
The firms, however, didn't reveal the investment amount in the joint venture.
"The new joint venture is a strategic move for us to consolidate our position in the consumer health care sector in world's second-largest over-the-counter market," said Hanspeter Spek, president for global operations at Sanofi-aventis.
For Minsheng Pharmaceutical, the new venture "will serve as a platform to develop more health products as well as expand the reach of our existing products," said Zhu Fujiang, its chairman.
The new venture will focus on manufacturing vitamins and mineral supplements as Minsheng Pharmaceutical is the patent holder of 21 Super-Vita, a multivitamin brand.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 娌狪CP璇侊細娌狪CP澶05050403鍙-1
- |
- 浜掕仈缃戞柊闂讳俊鎭湇鍔¤鍙瘉锛31120180004
- |
- 缃戠粶瑙嗗惉璁稿彲璇侊細0909346
- |
- 骞挎挱鐢佃鑺傜洰鍒朵綔璁稿彲璇侊細娌瓧绗354鍙
- |
- 澧炲肩數淇′笟鍔＄粡钀ヨ鍙瘉锛氭勃B2-20120012
Copyright 漏 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
